Learn more about whether Repligen Corporation or Bio-Techne Corporation is a better investment based on AAII's A+ Investor ...

Fintel reports that on March 18, 2025, Evercore ISI Group initiated coverage of Bio-Techne (NasdaqGS:TECH) with a Outperform ...

Bio-Techne Corporation ( NASDAQ:TECH ) shareholders might be concerned after seeing the share price drop 17% in ...

Evercore ISI initiated coverage of Bio-Techne (TECH) with an Outperform rating and $75 price target The firm believes that current volatility ...

Shares of Bio-Techne Co. (NASDAQ:TECH – Get Free Report) have been given a consensus rating of “Moderate Buy” by the eight ...

Bio-Techne was ordered on Feb. 26 by an arbitrator to pay its former CEO Charles Kummeth about $36 million after providing the wrong expiration date on granted options to buy about 779k shares of ...

Bio-Techne Corp. closed 27.36% short of its 52-week high of $85.57, which the company reached on May 15th.

The investment bank said Bio-Techne is a premium growth asset with a strong core business and growth verticals.

Buy” on shares of Bio-Techne as a short-term investment idea. The firm expects Bio-Techne to report fiscal Q3 results in line or above ...

Based in Minneapolis, Bio-Techne develops and markets protein-based instruments and reagents for research and clinical use. Its customers include companies in the pharmaceutical and biotech ...

MINNEAPOLIS, March 10, 2025 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that it has begun shipping the Leo™ System, powered by Simple Western™ Technology. Leo expands ...

Zurcher Kantonalbank Zurich Cantonalbank decreased its holdings in shares of Bio-Techne Co. (NASDAQ:TECH – Free Report) by 2.8% in the 4th quarter, according to the company in its most recent Form 13F ...